Bill R. Sanford is Founder and Chairman of Symark LLC, a technology commercialization and business development organization. He is a dedicated practitioner and outspoken advocate of Entrepreneurship, Innovation, and Biosciences Commercialization.
Mr. Sanford is an experienced entrepreneur, executive, consultant, investor, and board member with extensive new venture, merger and acquisition, turnaround, senior management, and market development experience. Since 1979, his direction of Symark has been focused on the development and commercialization of biosciences systems, products and services, clinical information systems, nanotechnology, and other innovative technology applications. He holds several patents related to medical devices and advanced technology.
Among his commercialization successes is Steris Corporation (NYSE:STE), a global leader in infection and contamination prevention systems, products, services, and technologies. As Executive Founder and Chairman of the Board, President, and Chief Executive Officer, he led Steris in only ten years from a start-up with five employees and a $3 million valuation to a NYSE-listed public company with 5,000 employees and a market value of over $2 billion.
Through Symark and multiple investment partnerships, Mr. Sanford is an active early stage and private equity investor. He serves as a board member and advisor of numerous public and private for-profit and not-for-profit organizations, including Greatbatch, Inc. (NYSE:GB), Cleveland Clinic, ElectroSonics Medical, Cardinal Commerce, BioEnterprise Corporation, and several early and growth stage technology companies.
Mr. Sanford is founding and past Chairman of BioEnterprise, a biosciences commercialization organization whose members and equal partners include Case Western Reserve University, Cleveland Clinic, and University Hospitals Health System. In addition, Mr. Sanford is Chairman Emeritus of NorTech (Northeast Ohio Regional Technology Coalition), former Vice Chairman of BioOhio, a charter member of the State of Ohio Technology Action Board, former Vice Chairman of the Kansas Bioscience Authority, a Trustee of the Kansas State University Foundation, and a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).